Reginster JY - Search Results

1

Design for an ipriflavone multicenter European fracture study.

Reginster JY, Bufalino L, Christiansen C, Devogelaer JP, Gennari C, Riis BJ, Roux C. Reginster JY, et al. Calcif Tissue Int. 1997;61 Suppl 1:S28-32. doi: 10.1007/s002239900382. Calcif Tissue Int. 1997. PMID: 9263614 Clinical Trial.

2

Effect of transdermal 17 beta-estradiol and oral conjugated equine estrogens on biochemical parameters of bone resorption in natural menopause.

Reginster JY, Christiansen C, Dequinze B, Deroisy R, Gaspard U, Taquet AN, Franchimont P. Reginster JY, et al. Calcif Tissue Int. 1993 Jul;53(1):13-6. doi: 10.1007/BF01352008. Calcif Tissue Int. 1993. PMID: 8394191 Clinical Trial.

3

[How to evaluate osteoporosis: bone densitometry and biochemical tests].

Reginster JY, Devogelaer JP, Kaufman JM, Appelboom T, Vanhaelst L. Reginster JY, et al. Rev Med Liege. 1999 Mar;54(3):184-8. Rev Med Liege. 1999. PMID: 10321109 Free article. French.

4

Recommendations for the registration of drugs intended for use in the treatment of male osteoporosis.

Kaufman JM, Compston J, Audran MA, Avouac B, Devogelaer JP, Lemmel EM, Vanhaelst L, Reginster JY. Kaufman JM, et al. Among authors: reginster jy. Calcif Tissue Int. 1999 Jul;65(1):4-7. doi: 10.1007/s002239900649. Calcif Tissue Int. 1999. PMID: 10369725 Review. No abstract available.

5

[Postmenopausal osteoporosis in women].

Reginster JY, Devogelaer JP, Kaufman JM, Appelboom T, Vanhaelst L. Reginster JY, et al. Rev Med Liege. 1999 Apr;54(4):335-40. Rev Med Liege. 1999. PMID: 10389480 Free article. French.

6

Association of tibolone and fluoride displays a pronounced effect on bone mineral density in postmenopausal osteoporotic women.

Reginster JY, Agnusdei D, Gennari C, Kicovic PM. Reginster JY, et al. Gynecol Endocrinol. 1999 Oct;13(5):361-8. doi: 10.3109/09513599909167580. Gynecol Endocrinol. 1999. PMID: 10599554 Free article. Clinical Trial.

7

[Involutional osteoporosis in women: therapeutic strategy. Recommendations of the Belgian Bone Club].

Kaufman JM, Body JJ, Boonen S, Devogelaer JP, Raeman F, Rozenberg S, Reginster JY. Kaufman JM, et al. Among authors: reginster jy. Rev Med Liege. 2000 May;55(5):443-8. Rev Med Liege. 2000. PMID: 10941311 Free article. French.

8

Do estrogens effectively prevent osteoporosis-related fractures? The Group for the Respect of Ethics and Excellence in Science.

Reginster JY, Bruyere O, Audran M, Avouac B, Body JJ, Bouvenot G, Brandi ML, Gennari C, Kaufman JM, Lemmel EM, Vanhaelst L, Weryha G, Devogelaer JP. Reginster JY, et al. Calcif Tissue Int. 2000 Sep;67(3):191-4. doi: 10.1007/s002230001135. Calcif Tissue Int. 2000. PMID: 10954771 Free article. Review. No abstract available.

9

Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.

Alexandersen P, Toussaint A, Christiansen C, Devogelaer JP, Roux C, Fechtenbaum J, Gennari C, Reginster JY; Ipriflavone Multicenter European Fracture Study. Alexandersen P, et al. Among authors: reginster jy. JAMA. 2001 Mar 21;285(11):1482-8. doi: 10.1001/jama.285.11.1482. JAMA. 2001. PMID: 11255425 Clinical Trial.

10

Intermittent cyclic tiludronate in the treatment of osteoporosis.

Reginster JY, Christiansen C, Roux C, Fechtenbaum J, Rouillon A, Tou KP. Reginster JY, et al. Osteoporos Int. 2001;12(3):169-77. doi: 10.1007/s001980170126. Osteoporos Int. 2001. PMID: 11315234 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

994 results

Search Page

Filters